Heinz Hammerlindl ASDR-AWTRS-MEPSA 2018 Joint Meeting

Abstracts this author is presenting:

• Therapy induced cellular reprogramming leads to metabolic vulnerabilities before the emergence of permanent acquired drug resistance in BRAF mutant melanoma — Session 2 - Cutaneous Melanoma